Topical antifungal treatment
Patent 6080744 Issued on June 27, 2000. Estimated Expiration Date: 
February 10, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
February 10, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 2832126 3334126 3517100 3705172 3717655 Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles 1-(1,3-Dioxolan-2-ylmethyl)-1H-1,2,4-triazoles Transdermal drug delivery system and method Liquid polymer composition and method of use Method of treating candida and cryptococcus fungal infections by administering gentian Patent #: 5837254 InventorApplicationNo. 247954 filed on 02/10/1999US Classes:514/254.07, Chalcogen hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding514/396, Imidazoles514/460, Chalcogen bonded directly to ring carbon of the hetero ring514/481, Naphthyl ring system514/558Higher fatty acid or salt thereofExaminersPrimary: Cintins, Marianne M.Assistant: Kim, Vickie Attorney, Agent or FirmInternational ClassesA61K 031/50A61K 031/495 A61K 031/20 A61K 031/35 A61K 031/415 AbstractA topical mycological treatment composition for medical, veterinarian, or dental use contains as active ingredients clotrimazole, ketoconazole, micanazole, nystatin, tolnaftate, propionic acid, sodium propionate, undecelynic acid, and zinc undecelynate. These ingredients are contained in a natural cream base, and the base may also contain an anti-inflammatory agent and an antibacterial agent.Other References
| |
